tiprankstipranks
Seelos Therapeutics (SEEL)
NASDAQ:SEEL

Seelos Therapeutics (SEEL) Ownership - Who Owns Seelos Therapeutics?

1,099 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 01, 2023Bought$99600
Dec 01, 2023
Raj Mehra
President, Ceo And Cob Of Directors
Bought$99999

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,831,324Insider57.24%3,414,457
724,571Institution5.30%315,913
513,330Institution3.75%223,812
280,866Institution2.05%122,458
214,527Institution1.57%93,534
155,396Insider1.14%67,753
115,891Insider0.85%50,528
87,547Institution0.64%38,170
73,332Institution0.54%31,973
55,735Insider0.41%24,300

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
214,527Institution1.57%93,534
87,547Institution0.64%38,170
73,332Institution0.54%31,973
39,148Institution0.29%17,069
24,583Institution0.18%10,718
2,438Institution0.02%1,063
-10,804Institution0.08%-4,711

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
513,330Institution3.75%223,812
224,893Institution1.64%132,912
55,973Institution0.41%33,080

FAQ

Who Owns Seelos Therapeutics (SEEL)?
Currently, no data Available
What percentage of Seelos Therapeutics (SEEL) stock is held by institutional investors?
Currently, no data Available
What percentage of Seelos Therapeutics (SEEL) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Seelos Therapeutics (SEEL)?
Alexander Denner owns the most shares of Seelos Therapeutics (SEEL).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis